Definium to present Phase 3 DT120 trial data at Psych Congress 2026

September 10, 2026 7:00 AM

Definium Therapeutics (Nasdaq: DFTX) announced it will present six poster presentations at Psych Congress, taking place September 15 through 19 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found